No abstract available
MeSH terms
-
Antihypertensive Agents / therapeutic use
-
Aspirin / therapeutic use
-
Cardiovascular Diseases / diagnosis
-
Cardiovascular Diseases / epidemiology
-
Cardiovascular Diseases / mortality
-
Cardiovascular Diseases / prevention & control*
-
Endpoint Determination
-
Evidence-Based Medicine
-
Health Policy
-
Health Promotion
-
Humans
-
Hypolipidemic Agents / therapeutic use
-
Incidence
-
National Health Programs* / legislation & jurisprudence
-
Platelet Aggregation Inhibitors / therapeutic use
-
Preventive Health Services* / legislation & jurisprudence
-
Prognosis
-
Program Development
-
Public Health* / legislation & jurisprudence
-
Risk Assessment
-
Risk Factors
-
Risk Reduction Behavior
-
Smoking Cessation
-
United States
-
Weight Loss
Substances
-
Antihypertensive Agents
-
Hypolipidemic Agents
-
Platelet Aggregation Inhibitors
-
Aspirin